A Florida citrus grower, an Argentine farmland owner, and a 'mysterious' California company crop up on my list.
Just about a week ago we looked at this chipmaker and since it's been powering ahead. Is it time to buy?
If we believe normalcy will return to the U.S. financial system, this investing plan could give outsized returns.
Here's what to avoid.
Software work management firm MNDY is sporting some bullish charts. Let's check the price targets ahead.
Insider buying by the new CEO of this buyer of biopharmaceutical royalties, puts this name on my radar.
The AI frenzy is taking a rest, and the number of stocks that are attracting speculative interest is very slim.
Let's review the charts of this cybersecurity name.
This balance sheet needs a lot of work.
The technical signals aren't yielding a clear answer to that question.